TYRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TYRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tyra Biosciences's Enterprise Value is $775.51 Mil. Tyra Biosciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-79.95 Mil. Therefore, Tyra Biosciences's EV-to-EBIT for today is -9.70.
The historical rank and industry rank for Tyra Biosciences's EV-to-EBIT or its related term are showing as below:
During the past 5 years, the highest EV-to-EBIT of Tyra Biosciences was 16212.47. The lowest was -6429.87. And the median was 0.00.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tyra Biosciences's Enterprise Value for the quarter that ended in Dec. 2023 was $398.92 Mil. Tyra Biosciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-79.95 Mil. Tyra Biosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -20.04%.
The historical data trend for Tyra Biosciences's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tyra Biosciences Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
EV-to-EBIT | - | - | -10.73 | -1.24 | -4.99 |
Tyra Biosciences Quarterly Data | ||||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-EBIT | Get a 7-Day Free Trial | -1.24 | -7.61 | -8.52 | -5.50 | -4.99 |
For the Biotechnology subindustry, Tyra Biosciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Tyra Biosciences's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tyra Biosciences's EV-to-EBIT falls into.
Tyra Biosciences's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 775.506 | / | -79.945 | |
= | -9.70 |
Tyra Biosciences's current Enterprise Value is $775.51 Mil.
Tyra Biosciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-79.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tyra Biosciences (NAS:TYRA) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Tyra Biosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) | = | EBIT | / | Enterprise Value (Q: Dec. 2023 ) |
= | -79.945 | / | 398.91771 | |
= | -20.04 % |
Tyra Biosciences's Enterprise Value for the quarter that ended in Dec. 2023 was $398.92 Mil.
Tyra Biosciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-79.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Tyra Biosciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Bensen | officer: Chief Operating Officer | C/O TYRA BIOSCIENCES, INC, 2656 STATE STREET, CARLSBAD CA 92008 |
Todd Harris | director, officer: Chief Executive Officer | 30699 RUSSELL RANCH ROAD, SUITE 140, WESTLAKE VILLAGE CA 91362 |
Mva Investors, Llc | 10 percent owner | 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130 |
Aaron I. Davis | 10 percent owner | 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130 |
Alan Fuhrman | officer: Chief Financial Officer | C/O AMBIT BIOSCIENCES CORPORATION, 11080 ROSELLE STREET, SAN DIEGO CA 92121 |
Ali D. Fawaz | officer: General Counsel and Secretary | C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD CA 92008 |
John Stephen Healy | officer: General Counsel and Secretary | C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD CA 92008 |
Boxer Capital, Llc | 10 percent owner | 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130 |
Ra Capital Healthcare Fund Lp | director, 10 percent owner | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Robert J More | director, 10 percent owner | 680 S CACHE STREET, SUITE 100, BOX 10820, JACKSON WY 83001 |
Alta Partners Nextgen Fund Ii, L.p. | 10 percent owner | 4 EMBARCADERO CENTER, SUITE 2100, SAN FRANCISCO CA 94111 |
Cormorant Asset Management, Lp | 10 percent owner | 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116 |
Robert L. Hudkins | officer: Chief Technology Officer | C/O TYRA BIOSCIENCES, INC, 2656 STATE STREET, CARLSBAD CA 92008 |
Siddarth Subramony | director | C/O TYRA BIOSCIENCES, INC, 2656 STATE STREET, CARLSBAD CA 92008 |
Melissa Mccracken | director | C/O TYRA BIOSCIENCES, INC, 2656 STATE STREET, CARLSBAD CA 92008 |
From GuruFocus
By PRNewswire PRNewswire • 03-29-2023
By PRNewswire • 09-21-2023
By PRNewswire PRNewswire • 05-25-2023
By PRNewswire PRNewswire • 05-04-2023
By GuruFocus Research • 06-22-2023
By PRNewswire PRNewswire • 07-15-2022
By PRNewswire PRNewswire • 11-10-2022
By PRNewswire PRNewswire • 11-03-2022
By PRNewswire PRNewswire • 11-02-2022
By PRNewswire PRNewswire • 05-16-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.